GGrantIndex
Sort

59,101 grants matching hypertension

CENTER OF RESEARCH IN OBESITY AND CARDIOVASCULAR DISEASE (1P20 RR021954-01A1)

$2,082,003
Lisa A Cassis · University Of Kentucky · P20 · FY2008 · RR

SCOR-MOLECULAR GENETICS OF HYPERTENSION

$2,080,151
University Of Iowa · P50 · FY2001 · HL

Center of Research in Obesity and Cardiovascular Disease (1P20 RR021954-01A1)

$2,079,402
Lisa A Cassis · University Of Kentucky · P20 · FY2012 · GM

Endothelial Injury and Repair: CardioPulmonary Vascular Biology COBRE

$2,079,394
Sharon Irene Smith Rounds · Ocean State Research Institute, Inc. · P20 · FY2015 · GM

Irreversible Kidney Injury in Renovascular Hypertension

$2,078,762
Lilach O Lerman · Mayo Clinic Rochester · P01 · FY2009 · HL

Cytokines and angiotensin II-induced hypertension

$2,078,758
R Clinton Webb · Augusta University · P01 · FY2008 · HL

Family and Neighborhood Interventions to Reduce Heart Disease Risk in East L.A.

$2,078,502
Alexander N Ortega · University Of California Los Angeles · P50 · FY2014 · HL

Native-Controlling Hypertension And Risk through Technology (Native-CHART)

$2,078,480
Dedra S Buchwald · Washington State University · U54 · FY2016 · MD

GENERAL CLINICAL RESEARCH CENTER

$2,077,270
Richard N Fine · State University New York Stony Brook · M01 · FY2007 · RR

Protective Mechanisms In Cerebral Ischemia

$2,077,086
John Hallenbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS

Irreversible Kidney Injury in Renovascular Hypertension

$2,077,066
Lilach O Lerman · Mayo Clinic Rochester · P01 · FY2010 · HL

Genes, environmental stressors, and the biobehavioral pathways to CVD

$2,075,030
Redford B Williams · Duke University · P01 · FY2019 · HL

Biology and Therapeutics of Cardiovascular Peptides

$2,074,421
John C Burnett · Mayo Clinic Rochester · P01 · FY2009 · HL

Excess nutrients and the metabolic syndrome of aging

$2,074,340
Albert Einstein Col Of Med Yeshiva Univ · P01 · FY2004 · AG

CLINICAL TRIAL OF ACUPUNCTURE FOR TREATING HYPERTENSION

$2,072,349
New England Research Institutes, Inc. · U01 · FY2001 · AT

Vascular remodeling in patients with rare genetic disorders

$2,072,321
Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

Integrated Mechanisms of Cardiac Maladaptation

$2,071,418
R John Solaro · University Of Illinois At Chicago · P01 · FY2020 · HL

Barber-Pharmacist Coordination to Improve Blood Pressure Management in Black Men

$2,071,138
Ronald G Victor · Cedars-Sinai Medical Center · R01 · FY2014 · HL

Adaptations to Hypoxia

$2,070,976
Kurt R Stenmark · University Of Colorado Denver · P01 · FY2012 · HL

Long-term Endotypes of Prematurity Associated Respiratory Disease (LEOPARD)

$2,070,206
Aaron Hamvas · Lurie Children'S Hospital Of Chicago · R01 · FY2024 · HL

SCOR-MOLECULAR GENETICS OF HYPERTENSION

$2,068,817
University Of Iowa · P50 · FY2002 · HL

20 YEAR CHANGES IN FITNESS & CARDIOVASCULAR DISEASE RISK

$2,068,590
Stephen Sidney · Kaiser Foundation Research Institute · R01 · FY2006 · HL

Cytokines and angiotensin II-induced hypertension

$2,068,401
Medical College Of Georgia (Mcg) · P01 · FY2004 · HL

CORAL: Clinical Coordinating Center

$2,068,167
University Of Toledo Health Sci Campus · U01 · FY2004 · HL

Project 2: Aging Healthy Together: Precision Profiles of Resilience and Risk

$2,068,060
Lee Ryan · University Of Arizona · U19 · FY2022 · AG